Follow-up Repeat metabolic markers after 4-12 weeks, with closer review during dose escalation or major appetite changes
Blocking NNMT is expected to raise SAM availability, but SAM participates in many cellular processes, so research must establish that selectively raising it does not perturb other methylation pathways
It is necessary for the proper function of the mitochondria, the energy-producing structures in cells
BPC-157 has been studied for its potential to reduce systemic inflammation, providing relief from pain and discomfort while enhancing overall mobility and well-being
Neuroprotective Properties Potential role in brain injury recovery and cognitive support It may protect against neurodegeneration It could help in cases of stroke recovery 6
References Jzwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P